Movatterモバイル変換

[0]ホーム
URL:

Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Nature
  • NEWS FEATURE

Rogue antibodies could be driving severe COVID-19

Evidence is growing that self-attacking ‘autoantibodies’ could be the key to understanding some of the worst cases of SARS-CoV-2 infection.
By
  1. Roxanne Khamsi

    1. Roxanne Khamsi is a science journalist based in Montreal, Canada.

Medical workers wearing protective gear treat a COVID-19 patient lying on his front on a bed in an intensive-care unit

Physicians treat a person with COVID-19 at a hospital’s intensive-care unit in the Czech Republic. Credit: Gabriel Kuchta/Getty

More than a year after COVID-19 emerged, many mysteries persist about the disease: why do some people get so much sicker than others? Why does lung damage sometimes continue to worsen well after the body seems to have cleared the SARS-CoV-2 virus? And what is behind the extended, multi-organ illness that lasts for months in people with ‘long COVID’? A growing number of studies suggest that some of these questions might be explained by the immune system mistakenly turning against the body — a phenomenon known as autoimmunity.

Access options

Access Nature and 54 other Nature Portfolio journals

Get Nature+, our best-value online-access subscription

9,800 Yen / 30 days

cancel any time

Subscription info for Japanese customers

We have a dedicated website for our Japanese customers. Please go tonatureasia.com to subscribe to this journal.

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Nature590, 29-31 (2021)

doi: https://doi.org/10.1038/d41586-021-00149-1

References

  1. Bastard, P.et al.Science370, eabd4585 (2020).

    Article PubMed  Google Scholar 

  2. Pozetto, B., Mogensen, K. E., Tovey, M. G. & Gresser, I.J.Infect. Dis.150, 707–713 (1984).

    Article PubMed  Google Scholar 

  3. Wang, E. Y.et al. Preprint at medRxivhttps://doi.org/10.1101/2020.12.10.20247205 (2020).

  4. Zuo, Y.et al.Sci. Transl. Med.12, eabd3876 (2020).

    Article PubMed  Google Scholar 

  5. Zuniga, M.et al. Preprint at medRxivhttps://doi.org/10.1101/2020.12.28.20248807 (2021).

  6. Ehrenfeld, M.et al.Autoimmun. Rev.19, 102597 (2020).

    Article PubMed  Google Scholar 

  7. Zulfiqar, A.-A., Lorenzo-Villalba, N., Hassler, P. & Andrès, E.N.Engl. J. Med.382, e43 (2020).

    Article PubMed  Google Scholar 

  8. Bhattacharjee, S. & Banerjee, M.SN Compr.Clin. Med. https://doi.org/10.1007/s42399-020-00521-8 (2020).

    Article  Google Scholar 

  9. Monk, P. D.et al.Lancet Respir. Med. https://doi.org/10.1016/S2213-2600(20)30511-7 (2020).

    Article  Google Scholar 

  10. The REMAP-CAP Investigatorset al. Preprint at medRxivhttps://doi.org/10.1101/2021.01.07.21249390 (2021).

Download references

Reprints and permissions

Related Articles

Subjects

Latest on:

Nature Careers

Jobs

Related Articles

Subjects

Sign up to Nature Briefing

An essential round-up of science news, opinion and analysis, delivered to your inbox every weekday.

Nature Briefing

Sign up for theNature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox.Sign up for Nature Briefing

Search

Advanced search

Quick links

[8]ページ先頭
©2009-2026 Movatter.jp